mitozolomide has been researched along with Leukopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackledge, G; de Stavola, B; Kaye, S; Roberts, JT; Taylor, R; Uscinska, B; Williams, J | 1 |
| Green, JA; Harding, M; Newlands, E; Northcott, D; Smyth, J; Stuart, NS | 1 |
2 other study(ies) available for mitozolomide and Leukopenia
| Article | Year |
|---|---|
A phase II study of mitozolomide in metastatic transitional cell carcinoma of the bladder.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Nitrogen Mustard Compounds; Thrombocytopenia; Urinary Bladder Neoplasms | 1989 |
Phase II evaluation of mitozolomide in ovarian cancer.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Nitrogen Mustard Compounds; Ovarian Neoplasms; Thrombocytopenia | 1988 |